Optimal Combination Therapy After Nevirapine Exposure.

Trial Profile

Optimal Combination Therapy After Nevirapine Exposure.

Phase of Trial: Phase III

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Nevirapine (Primary) ; Emtricitabine; Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir; Tenofovir dipivoxil fumarate; Tenofovir disoproxil fumarate
  • Indications HIV-1 infections
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms OCTANE; OCTANE-1
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 08 Mar 2012 Extension study results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
    • 11 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top